sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Small Interfering Rna Sirna Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00008765
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato e dei concorrenti dei farmaci a base di RNA interferente piccolo (siRNA) entro il 2025-2031

Buy Now

Small Interfering RNA (siRNA) Therapeutics Market Report Small Interfering RNA (siRNA) Therapeutics Market Size and Share Small Interfering RNA (siRNA) Therapeutics Market Scope and Analysis

Small Interfering RNA (siRNA) Therapeutics Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Indicazione
  • Oncologia
  • Malattie cardiovascolari
  • Patologie respiratorie
  • Patologie neurodegenerative
  • Malattie infettive
  • Altro
By Tipi
  • terapia sistemica basata su liposomi
  • terapia sistemica basata su nanoparticelle
  • altro
By Utente finale
  • laboratorio diagnostico
  • laboratori di ricerca e accademici
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Horizon Discovery
  • GlaxoSmithKline
  • Sirna Therapeutics, Inc.
  • Alnylam Pharmaceuticals
  • Sanofi Genzyme
  • Olix Pharmaceuticals
  • Silence Therapeutics AG
  • Calando Pharmaceuticals
  • Arbutus Biopharma Corp